Gramine

Gramine

SCHEMBL7434281

CI.CN(C)Cc1c[nH]c2ccccc12

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.93
KMT2A Q03164 4/20 0.93
MEN1 O00255 3/20 0.93
KDM4E B2RXH2 3/20 0.93
HSD17B10 Q99714 2/20 0.93
CYP3A4 P08684 2/20 0.93
CYP2D6 P10635 1/20 0.93
TSHR P16473 1/20 0.93
CYP2C19 P33261 1/20 0.93
MAPT P10636 4/20 0.65
HTR2A P28223 3/20 0.65
HTR2C P28335 3/20 0.65
HTR2B P41595 3/20 0.65
HTR1A P08908 3/20 0.65
HPGD P15428 1/20 0.65
LMNA P02545 3/20 0.64
GAA P10253 1/20 0.64
SLC6A4 P31645 2/20 0.61
AHR P35869 1/20 0.58
GPR84 Q9NQS5 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gramine SCHEMBL63578 0.96 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1KDM4EHSD17B10
Gramine SCHEMBL29351803 0.96 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1KDM4EHSD17B10
Gramine SCHEMBL9058128 0.95 ALDH1A1 (0.96) ALDH1A1KMT2AMEN1KDM4EHSD17B10
Gramine SCHEMBL8704815 0.88 ALDH1A1 (0.72) ALDH1A1KMT2AMEN1KDM4EHSD17B10
Gramine SCHEMBL20906415 0.84 ALDH1A1 (0.77) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL947574 0.81 KMT2A (0.73) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL22619123 0.81 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1KDM4EHSD17B10
N,N-Dimethyltryptamine SCHEMBL335710 0.79 HTR2A (1.00) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL1027348 0.79 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1KDM4EHSD17B10
N,N-Dimethyltryptamine SCHEMBL29350959 0.79 HTR2A (1.00) ALDH1A1KMT2AMEN1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012117216-A1 N- (ARYLALKYL) - 1H- INDOLE- 2 - SULFONIC ACID AMIDE COMPOUNDS AND THEIR THERAPEUTIC USE AS CANNABINOID ALLOSTERIC MODULATORS THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2012-09-07 WO disclosed
US-5846942-A Cholecystokinin antagonists, their preparation and therapeutic use WARNER-LAMBERT COMPANY (US) 1998-12-08 US disclosed
US-5593967-A Cholecystokinin antagonists, their preparation and therapeutic use WARNER-LAMBERT COMPANY (US) 1997-01-14 US disclosed
US-5340802-A Central nervous system disorders ABBOTT LABORATORIES (US) 1994-08-23 US disclosed
EP-0547178-A4 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER LAMBERT CO (US) 1994-07-06 EP disclosed
EP-0547178-A1 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER-LAMBERT COMPANY (US) 1993-06-23 EP disclosed
EP-0167919-B1 BENZODIAZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1993-05-05 EP disclosed
US-5175159-A Prevention of premature labor MERCK & CO., INC. (US) 1992-12-29 US disclosed
WO-1992004045-A1 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed
EP-0421802-A2 3-substituted-1,4-benzodiazepines useful as oxytocin antagonists MERCK & CO. INC. (US) 1991-04-10 EP disclosed
EP-0167919-A2 Benzodiazepine derivatives and pharmaceutical compositions containing them MERCK & CO. INC. (US) 1986-01-15 EP disclosed
EP-0008657-B1 ALPHA-VINYL-ALPHA-AMINOACIDS AND THEIR ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1983-03-30 EP disclosed
EP-0008658-B1 ALPHA-ETHINYL-ALPHA-AMINOACIDS AND THEIR ESTERS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1982-12-01 EP disclosed
US-4347375-A Process for preparing amino acids and esters MERCK & CO., INC. (US) 1982-08-31 US disclosed
EP-0007615-B1 PROCESS FOR PREPARING AMINO ACIDS AND ESTERS MERCK & CO. INC. (US) 1982-06-16 EP disclosed
US-4275220-A N-(BENZYLIDENE OR ALKYLIDENE)-2-AMINOCROTONATE CHEMICAL INTERMEDIATE MERCK & CO., INC. (US) 1981-06-23 US disclosed
EP-0008658-A1 Alpha-ethinyl-alpha-aminoacids and their esters, and pharmaceutical compositions containing them MERCK & CO. INC. (US) 1980-03-19 EP disclosed
EP-0008657-A1 Alpha-vinyl-alpha-aminoacids and their esters and pharmaceutical compositions containing them MERCK & CO. INC. (US) 1980-03-19 EP disclosed
EP-0007615-A2 Process for preparing amino acids and esters MERCK & CO. INC. (US) 1980-02-06 EP disclosed
US-4065464-A Process for the preparation of substituted trichloroacetamidine derivatives MERCK & CO., INC. (US) 1977-12-27 US disclosed